Charlotte R Williams Selected Research

Charlotte R Williams Research Topics

Disease

20	Neoplasms (Cancer) 01/2017 - 07/2003
11	Carcinogenesis 01/2016 - 10/2007
11	Breast Neoplasms (Breast Cancer) 01/2015 - 10/2002
8	Lung Neoplasms (Lung Cancer) 01/2016 - 07/2006
6	Inflammation (Inflammations) 01/2017 - 07/2006
3	Leukemia 10/2015 - 07/2003
3	Carcinoma (Carcinomatosis) 10/2015 - 03/2007
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2010
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Parkinson Disease (Parkinson's Disease) 01/2013
1	Adenocarcinoma of Lung 12/2009
1	Hyperplasia 05/2008
1	Adenocarcinoma 03/2007
1	Melanoma (Melanoma, Malignant) 07/2003

Drug/Important Bio-Agent (IBA)

13	TriterpenesIBA 07/2015 - 07/2003
9	bardoxolone methylIBA 07/2015 - 09/2004
8	LG 100268IBA 01/2016 - 10/2002
8	bardoxoloneIBA 10/2015 - 07/2003
7	CarcinogensIBA 01/2016 - 10/2002
6	Proteins (Proteins, Gene)FDA Link 01/2017 - 07/2007
6	vinyl carbamateIBA 01/2016 - 03/2007
6	Estrogen ReceptorsIBA 01/2013 - 05/2004
6	AcidsIBA 05/2012 - 09/2004
4	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 10/2015 - 07/2003
4	EstersIBA 05/2012 - 03/2007
3	Pharmaceutical PreparationsIBA 07/2015 - 05/2004
3	oleananeIBA 07/2015 - 12/2009
3	2- cyano- 3,12- dioxooleana- 1,9(11)- dien- 28- oic acid ethyl amideIBA 11/2010 - 03/2007
3	Selective Estrogen Receptor Modulators (SERM)IBA 10/2006 - 10/2002
3	LY 353381 (LY353381)IBA 10/2006 - 10/2002
2	Interleukin-6 (Interleukin 6)IBA 01/2017 - 07/2008
2	Histone Deacetylase InhibitorsIBA 01/2016 - 01/2013
2	Vorinostat FDA Link 01/2016 - 01/2013
2	Drug CombinationsIBA 01/2013 - 10/2006
2	ChemokinesIBA 01/2013 - 05/2012
2	ErbB Receptors (EGF Receptor)IBA 05/2012 - 05/2008
2	Cyclin D1IBA 05/2012 - 01/2012
2	Synthetic DrugsIBA 11/2010 - 12/2009
2	LG 268IBA 11/2010 - 05/2008
2	AGN 194204IBA 12/2009 - 10/2007
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008 - 07/2007
2	EnzymesIBA 08/2008 - 07/2007
2	AmidesIBA 05/2008 - 03/2007
2	Transcription Factors (Transcription Factor)IBA 03/2007 - 07/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017
1	CytokinesIBA 01/2017
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2016
1	7- (2- (2,2- difluoroethoxy)- 3,5- di- tert- butylbenzene)- 3- methylocta- 2,4,6- trienoic acidIBA 01/2016
1	Dimethyl FumarateIBA 07/2015
1	Lapatinib (GW572016)FDA Link 01/2015
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2015
1	Trastuzumab (Herceptin)FDA Link 01/2015
1	veliparibIBA 07/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 07/2014
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2014
1	olaparibIBA 07/2014
1	Messenger RNA (mRNA)IBA 01/2013
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2013
1	A 7 (A-7)IBA 01/2013
1	Macrophage Colony-Stimulating FactorIBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 05/2012
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2012
1	Gemcitabine FDA Link 11/2010
1	NF-E2-Related Factor 2IBA 06/2009
1	AflatoxinsIBA 08/2008
1	TBE 31IBA 08/2008
1	Biological ProductsIBA 05/2008
1	LigandsIBA 05/2008
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 05/2008
1	Retinoid X Receptors (Retinoid X Receptor)IBA 05/2008
1	Betulinic AcidIBA 07/2007
1	Nitric Oxide Synthase (NO Synthase)IBA 03/2007
1	Heme Oxygenase-1IBA 03/2007
1	ritetroniumIBA 10/2006
1	Transforming Growth Factor beta (TGF-beta)IBA 05/2004
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 10/2002

Therapy/Procedure

5	Chemoprevention 07/2014 - 08/2008
2	Therapeutics 01/2017 - 07/2015
1	Oral Administration 01/2013
1	Drug Therapy (Chemotherapy) 08/2008